Cyber-Ark® Software recently designated Nick Baglin as the new vice president of sales for their EMEA offices. He was previously part of HP Enterprise Security Services where he had the post of global sales director. Baglin also worked for Vistorm in the past. There’s more about his appointment on this news link.
Mirna Therapeutics, Inc. will be looking into further research and product development with the help of their most recent equity funding round worth $1.5 million.
They have also enjoyed a couple of successful financing rounds from the Texas Emerging Technology Fund back in 2009 (worth $5 million) and in 2010 from the Cancer Prevention & Research Institute of Texas (CPRIT) (worth $10.3 million).
The company CEO Dr. Paul Lammers, MD, MSc has provided us more information about Mirna Therapeutics in this recent e-interview with Lead411: